Healthcare Industry News: IIb/IIIa

The Medicines Company Receives European Approval for Angiox(R) (Bivalirudin) for Use in Heart Attack Patients Undergoing Emergency Heart Procedures

Source: The Medicines Company

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!